Research graph

References

References from A mini review of Patisiran's efficacy in the management of transthyretin cardiac amyloidosis. Local targets link to admitted publications; unresolved targets remain external evidence.

10.1002/ehf2.12518

10.1002/ehf2.12518 · 2019 · External reference

10.1016/j.ccl.2022.06.008

10.1016/j.ccl.2022.06.008 · 2022 · External reference

10.1159/000522370

10.1159/000522370 · 2022 · External reference

10.1007/s11936-020-00844-8

10.1007/s11936-020-00844-8 · 2020 · External reference

10.1093/ajhp/zxab356

10.1093/ajhp/zxab356 · 2022 · External reference

10.2217/nmt-2018-0033

10.2217/nmt-2018-0033 · 2019 · External reference

10.1007/s40291-019-00434-w

10.1007/s40291-019-00434-w · 2020 · External reference

10.1080/17512433.2019.1567326

10.1080/17512433.2019.1567326 · 2019 · External reference

10.1056/nejmoa1805689

10.1056/nejmoa1805689 · 2018 · External reference

10.3390/jcm11082148

10.3390/jcm11082148 · 2022 · External reference

10.1016/j.cardfail.2023.10.043

10.1016/j.cardfail.2023.10.043 · 2024 · External reference

10.1016/j.cardfail.2023.10.035

10.1016/j.cardfail.2023.10.035 · 2024 · External reference

10.1161/circ.148.suppl_1.13273

10.1161/circ.148.suppl_1.13273 · External reference

10.1093/ehjci/jead119.396

10.1093/ehjci/jead119.396 · 2023 · External reference

10.1016/j.jcmg.2020.07.043

10.1016/j.jcmg.2020.07.043 · 2021 · External reference

10.1001/jamacardio.2019.0849

10.1001/jamacardio.2019.0849 · 2019 · External reference

10.1161/circulationaha.118.035831

10.1161/circulationaha.118.035831 · 2019 · External reference

10.1056/nejmoa2300757

10.1056/nejmoa2300757 · 2023 · External reference

10.1053/j.jvca.2024.02.035

10.1053/j.jvca.2024.02.035 · 2024 · External reference

10.1007/s10286-019-00629-5

10.1007/s10286-019-00629-5 · 2019 · External reference

10.1007/s12254-021-00678-5

10.1007/s12254-021-00678-5 · 2021 · External reference

10.1080/17460441.2024.2306843

10.1080/17460441.2024.2306843 · 2024 · External reference